Skip to main content
Fig. 5 | BMC Microbiology

Fig. 5

From: Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections

Fig. 5

Anticoagulant effects of TFPI-2 derived peptides. a The activated partial thromboplastin time (aPTT) was determined by addition of buffer or 50 μM of different vertebrate TFPI-2 derived peptides to human plasma. Data are presented as clotting time in seconds; values are mean ± SD (n = 3). b Human erythrocytes were incubated with 60 μM of vertebrate TFPI-2 derived peptides. The hemoglobin release was measured at λ 540 nm and hemolysis was indicated in percentage, Triton X-100 treated sample being used a positive control

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us